Biotechnology

Garner Health Technology Named Honorable Mention in Fast Company’s 2023 World Changing Ideas Awards

by

NEW YORK, May 17, 2023 /PRNewswire/ — Garner Health Technology, Inc. today announced that its doctor search tool has been recognized with an honorable mention in Fast Company’s 2023 World Changing Ideas Awards. This annual Fast Company award celebrates “the sustainable designs, innovative products, bold social initiatives, and other creative projects that are changing the … Read more

PTC Therapeutics Announces APHENITY Trial Achieved Primary Endpoint with Sepiapterin in PKU Patients

by

– Highly statistically significant and clinically meaningful results – – 63% mean blood Phe reduction in primary analysis population (p<0.0001) – – Conference call and webcast to be held at 8:00 AM EDT – SOUTH PLAINFIELD, N.J., May 17, 2023 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the primary endpoint was achieved in … Read more

Researchers Reveal Newfound DNA Repair Mechanism

by

NEW YORK , May 17, 2023 /PRNewswire/ –A new study adds to an emerging, radically new picture of how bacterial cells continually repair faulty sections of their DNA.  Published online May 16 in the journal Cell, the report describes the molecular mechanism behind a DNA repair pathway that counters the mistaken inclusion of a certain type … Read more

The Cell Therapy Media Market, Cell Therapy Kits Market, Cell Therapy Reagents Market and Cell Therapy Surface Market is anticipated to grow at an annualized rate of 12% by 2035, claims Roots Analysis

by

Owing to the growing number of approvals of cell therapies, and a continuous rise in number of associated clinical trials, the demand for advanced cell therapy consumables is likely to witness significant rise in the coming years LONDON, May 17, 2023 /PRNewswire/ — Roots Analysis has announced the addition of Cell Therapy Media Market, Cell Therapy Kits … Read more

New Computational Tool Identifies Novel Targets for Cancer Immunotherapy

by

–Study led by CHOP and UCLA demonstrates the power of using big data and multi-omics to discover novel tumor antigens derived from alternative RNA splicing– PHILADELPHIA, May 17, 2023 /PRNewswire/ — Researchers at Children’s Hospital of Philadelphia (CHOP) and the University of California, Los Angeles (UCLA) have developed a computational platform capable of discovering tumor … Read more

Sirnaomics to receive HK$8 million subsidy from the HKSTP Clinical Translational Catalyst Plan

by

HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, May 17, 2023 /PRNewswire/ — Sirnaomics Ltd. (the “Company”; together with its subsidiaries, the “Group” or “Sirnaomics”; stock code: 2257), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, has received approval of an HK$8 million subsidy from the Hong Kong Science and Technology Parks Corporation … Read more

Memora Health Partners With SUNY Downstate Health Sciences University to Support Patients After Discharge

by

Partnership Will Streamline Transitions of Care With Automated Touchpoints to Reach More Patients and Unburden Care Teams SAN FRANCISCO, May 17, 2023 /PRNewswire/ — Memora Health, the leading intelligent care enablement platform, today announced a partnership with SUNY Downstate Health Sciences University. As Brooklyn’s only academic medical center for health education, research, and patient care, … Read more

New Menarini Silicon Biosystems partnership with Alivio Health expands patient access to CELLSEARCH® liquid biopsy tests

by

Menarini Silicon Biosystems just signed a partnership with Alivio Health to provide preferred access, to their clients and members, to the minimally invasive CELLSEARCH® CTC tests so that more cancer patients may benefit from real-time information on disease status and response to therapy. BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., May 17, 2023 /PRNewswire/ — Menarini … Read more

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS

by

BEIJING, May 17, 2023 /PRNewswire/ — CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported financial results for the three months ended March 31, 2023. Wei-Wu He, Ph.D., CASI’s Chairman and Chief Executive Officer, commented, “Revenue for EVOMELA® was $8.3 million … Read more

Platelet Rich Plasma Market to Showcase Excellent Growth- Brandessence Market Research

by

LONDON, May 17, 2023 /PRNewswire/ — Platelet-rich plasma (PRP) is revolutionizing the field of regenerative medicine. Derived from a patient’s own blood, this golden elixir has the potential to heal and rejuvenate damaged tissues. PRP is enriched with a concentrated dose of platelets along with bioactive proteins and acts as a powerful stimulant, triggering natural repair … Read more